The DOI matches its Crossref record; 161 of the 161 references it cites were found in a registry or an index.
Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update
Open accessAbstract
During the past decade, cancer stem cells (CSCs) have been increasingly identified in many malignancies. Although the origin and plasticity of these cells remain controversial, tumour heterogeneity and the presence of small populations of cells with stem-like characteristics is established in most malignancies. CSCs display many features of embryonic or tissue stem cells, and typically demonstrate persistent activation of one or more highly conserved signal transduction pathways involved in development and tissue homeostasis, including the Notch, Hedgehog (HH), and Wnt pathways. CSCs generally have slow growth rates and are resistant to chemotherapy and/or radiotherapy. Thus, new treatment strategies targeting these pathways to control stem-cell replication, survival and differentiation are under development. Herein, we provide an update on the latest advances in the clinical development of such approaches, and discuss strategies for overcoming CSC-associated primary or acquired resistance to cancer treatment. Given the crosstalk between the different embryonic developmental signalling pathways, as well as other pathways, designing clinical trials that target CSCs with rational combinations of agents to inhibit possible compensatory escape mechanisms could be of particular importance. We also share our views on the future directions for targeting CSCs to advance the clinical development of these classes of agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
The Wnt Signaling Pathway in Development and Disease
Logan, C. Y., & Nusse, R. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.010403.113126 · Cited by 5,325
A restricted cell population propagates glioblastoma growth after chemotherapy
Chen, J., Li, Y., Yu, T.-S., McKay, R. M., Burns, D. K., Kernie, S. G., & Parada, L. F. (2012) · Nature · doi:10.1038/nature11287 · Cited by 2,354
Wnt proteins are lipid-modified and can act as stem cell growth factors
Willert, K., Brown, J. D., Danenberg, E., Duncan, A. W., Weissman, I. L., Reya, T., Yates, J. R., & Nusse, R. (2003) · Nature · doi:10.1038/nature01611 · Cited by 2,257
Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
Huang, S.-M. A., Mishina, Y. M., Liu, S., Cheung, A., Stegmeier, F., Michaud, G. A., Charlat, O., Wiellette, E., Zhang, Y., Wiessner, S., et al. (2009) · Nature · doi:10.1038/nature08356 · Cited by 2,037
Human Homolog of patched , a Candidate Gene for the Basal Cell Nevus Syndrome
Johnson, R. L., Rothman, A. L., Xie, J., Goodrich, L. V., Bare, J. W., Bonifas, J. M., Quinn, A. G., Myers, R. M., Cox, D. R., Epstein, E. H., et al. (1996) · Science · doi:10.1126/science.272.5268.1668 · Cited by 1,857
Wnt activity defines colon cancer stem cells and is regulated by the microenvironment
Vermeulen, L., De Sousa E Melo, F., van der Heijden, M., Cameron, K., de Jong, J. H., Borovski, T., Tuynman, J. B., Todaro, M., Merz, C., Rodermond, H., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2048 · Cited by 1,804
Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis
Hellström, M., Phng, L.-K., Hofmann, J. J., Wallgard, E., Coultas, L., Lindblom, P., Alva, J., Nilsson, A.-K., Karlsson, L., Gaiano, N., et al. (2007) · Nature · doi:10.1038/nature05571 · Cited by 1,775
van Es, J. H., van Gijn, M. E., Riccio, O., van den Born, M., Vooijs, M., Begthel, H., Cozijnsen, M., Robine, S., Winton, D. J., Radtke, F., et al. (2005) · Nature · doi:10.1038/nature03659 · Cited by 1,543
Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9
Krivtsov, A. V., Twomey, D., Feng, Z., Stubbs, M. C., Wang, Y., Faber, J., Levine, J. E., Wang, J., Hahn, W. C., Gilliland, D. G., et al. (2006) · Nature · doi:10.1038/nature04980 · Cited by 1,513
Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma
Sekulic, A., Migden, M. R., Oro, A. E., Dirix, L., Lewis, K. D., Hainsworth, J. D., Solomon, J. A., Yoo, S., Arron, S. T., Friedlander, P. A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113713 · Cited by 1,464
A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease
Doody, R. S., Raman, R., Farlow, M., Iwatsubo, T., Vellas, B., Joffe, S., Kieburtz, K., He, F., Sun, X., Thomas, R. G., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1210951 · Cited by 1,224
Cancer stem cells: an evolving concept
Nguyen, L. V., Vanner, R., Dirks, P., & Eaves, C. J. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3184 · Cited by 1,171
Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma
Von Hoff, D. D., LoRusso, P. M., Rudin, C. M., Reddy, J. C., Yauch, R. L., Tibes, R., Weiss, G. J., Borad, M. J., Hann, C. L., Brahmer, J. R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905360 · Cited by 1,109
Lineage Tracing Reveals Lgr5 + Stem Cell Activity in Mouse Intestinal Adenomas
Schepers, A. G., Snippert, H. J., Stange, D. E., van den Born, M., van Es, J. H., van de Wetering, M., & Clevers, H. (2012) · Science · doi:10.1126/science.1224676 · Cited by 1,072
LDL receptor-related proteins 5 and 6 in Wnt/β-catenin signaling:Arrows point the way
He, X., Semenov, M., Tamai, K., & Zeng, X. (2004) · Development · doi:10.1242/dev.01117 · Cited by 1,044
Can we safely target the WNT pathway?
Kahn, M. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4233 · Cited by 1,034
Self-citationTargeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways
Takebe, N., Harris, P. J., Warren, R. Q., & Ivy, S. P. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.196 · Cited by 992
Self-citationTackling the cancer stem cells — what challenges do they pose?
Pattabiraman, D. R., & Weinberg, R. A. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4253 · Cited by 990
Wnt signaling in disease and in development
NUSSE, R. (2005) · Cell Research · doi:10.1038/sj.cr.7290260 · Cited by 973
A paracrine requirement for hedgehog signalling in cancer
Yauch, R. L., Gould, S. E., Scales, S. J., Tang, T., Tian, H., Ahn, C. P., Marshall, D., Fu, L., Januario, T., Kallop, D., et al. (2008) · Nature · doi:10.1038/nature07275 · Cited by 961
Smoothened Mutation Confers Resistance to a Hedgehog Pathway Inhibitor in Medulloblastoma
Yauch, R. L., Dijkgraaf, G. J. P., Alicke, B., Januario, T., Ahn, C. P., Holcomb, T., Pujara, K., Stinson, J., Callahan, C. A., Tang, T., et al. (2009) · Science · doi:10.1126/science.1179386 · Cited by 839
Monounsaturated Fatty Acid Modification of Wnt Protein: Its Role in Wnt Secretion
Takada, R., Satomi, Y., Kurata, T., Ueno, N., Norioka, S., Kondoh, H., Takao, T., & Takada, S. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.10.003 · Cited by 788
Genome Sequencing of SHH Medulloblastoma Predicts Genotype-Related Response to Smoothened Inhibition
Kool, M., Jones, D. T. W., Jäger, N., Northcott, P. A., Pugh, T. J., Hovestadt, V., Piro, R. M., Esparza, L. A., Markant, S. L., Remke, M., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.02.004 · Cited by 762
Dishevelled: The hub of Wnt signaling
Gao, C., & Chen, Y.-G. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2009.11.021 · Cited by 755
Mining the Wnt pathway for cancer therapeutics
Barker, N., & Clevers, H. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2154 · Cited by 743
Wong, G. T., Manfra, D., Poulet, F. M., Zhang, Q., Josien, H., Bara, T., Engstrom, L., Pinzon-Ortiz, M., Fine, J. S., Lee, H.-J. J., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311652200 · Cited by 718
Defining the mode of tumour growth by clonal analysis
Driessens, G., Beck, B., Caauwe, A., Simons, B. D., & Blanpain, C. (2012) · Nature · doi:10.1038/nature11344 · Cited by 717
Cutaneous cancer stem cell maintenance is dependent on β-catenin signalling
Malanchi, I., Peinado, H., Kassen, D., Hussenet, T., Metzger, D., Chambon, P., Huber, M., Hohl, D., Cano, A., Birchmeier, W., et al. (2008) · Nature · doi:10.1038/nature06835 · Cited by 597
Milano, J., McKay, J., Dagenais, C., Foster-Brown, L., Pognan, F., Gadient, R., Jacobs, R. T., Zacco, A., Greenberg, B., & Ciaccio, P. J. (2004) · Toxicological Sciences · doi:10.1093/toxsci/kfh254 · Cited by 576
Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups
Ellison, D. W., Dalton, J., Kocak, M., Nicholson, S. L., Fraga, C., Neale, G., Kenney, A. M., Brat, D. J., Perry, A., Yong, W. H., et al. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0800-8 · Cited by 563
Buonamici, S., Williams, J., Morrissey, M., Wang, A., Guo, R., Vattay, A., Hsiao, K., Yuan, J., Green, J., Ospina, B., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001599 · Cited by 562
Unraveling the therapeutic potential of the Hedgehog pathway in cancer
Amakye, D., Jagani, Z., & Dorsch, M. (2013) · Nature Medicine · doi:10.1038/nm.3389 · Cited by 547
Regulation of Breast Cancer Stem Cell Activity by Signaling through the Notch4 Receptor
Harrison, H., Farnie, G., Howell, S. J., Rock, R. E., Stylianou, S., Brennan, K. R., Bundred, N. J., & Clarke, R. B. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1681 · Cited by 543
Leukaemogenesis induced by an activating β-catenin mutation in osteoblasts
Kode, A., Manavalan, J. S., Mosialou, I., Bhagat, G., Rathinam, C. V., Luo, N., Khiabanian, H., Lee, A., Murty, V. V., Friedman, R., et al. (2014) · Nature · doi:10.1038/nature12883 · Cited by 532
Itraconazole, a Commonly Used Antifungal that Inhibits Hedgehog Pathway Activity and Cancer Growth
Kim, J., Tang, J. Y., Gong, R., Kim, J., Lee, J. J., Clemons, K. V., Chong, C. R., Chang, K. S., Fereshteh, M., Gardner, D., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.02.027 · Cited by 527
Targeting Hedgehog — a Cancer Stem Cell Pathway
Merchant, A. A., & Matsui, W. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2846 · Cited by 500
Medicine, N. L. O. (2008) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.1080/15360280801989377 · Cited by 468
Therapeutic modulation of Notch signalling — are we there yet?
Andersson, E. R., & Lendahl, U. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4252 · Cited by 457
Phosphoinositide 3-kinase and Akt are essential for Sonic Hedgehog signaling
Riobó, N. A., Lu, K., Ai, X., Haines, G. M., & Emerson, C. P. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504337103 · Cited by 439
Diversity of LEF/TCF action in development and disease
Arce, L., Yokoyama, N. N., & Waterman, M. L. (2006) · Oncogene · doi:10.1038/sj.onc.1210056 · Cited by 438
Domingo-Domenech, J., Vidal, S. J., Rodriguez-Bravo, V., Castillo-Martin, M., Quinn, S. A., Rodriguez-Barrueco, R., Bonal, D. M., Charytonowicz, E., Gladoun, N., de la Iglesia-Vicente, J., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.07.016 · Cited by 416
Targeting Notch signaling pathway in cancer: Clinical development advances and challenges
Takebe, N., Nguyen, D., & Yang, S. X. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.09.005 · Cited by 413
Self-citationThe Hedgehog's tale: developing strategies for targeting cancer
Ng, J. M. Y., & Curran, T. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3079 · Cited by 398
DLL4 Blockade Inhibits Tumor Growth and Reduces Tumor-Initiating Cell Frequency
Hoey, T., Yen, W.-C., Axelrod, F., Basi, J., Donigian, L., Dylla, S., Fitch-Bruhns, M., Lazetic, S., Park, I.-K., Sato, A., et al. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.05.019 · Cited by 398
Tirino, V., Desiderio, V., Paino, F., De Rosa, A., Papaccio, F., La Noce, M., Laino, L., De Francesco, F., & Papaccio, G. (2013) · The FASEB Journal · doi:10.1096/fj.12-218222 · Cited by 395
Jagged1 is the pathological link between Wnt and Notch pathways in colorectal cancer
Rodilla, V., Villanueva, A., Obrador-Hevia, A., Robert-Moreno, À., Fernández-Majada, V., Grilli, A., López-Bigas, N., Bellora, N., Albà, M. M., Torres, F., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813221106 · Cited by 384
A Wnt Survival Guide: From Flies to Human Disease
Chien, A. J., Conrad, W. H., & Moon, R. T. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.445 · Cited by 376
Organoid cultures for the analysis of cancer phenotypes
Sachs, N., & Clevers, H. (2014) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2013.11.012 · Cited by 371
Cancer stem cells – old concepts, new insights
Vermeulen, L., Sprick, M. R., Kemper, K., Stassi, G., & Medema, J. P. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.20 · Cited by 352
The Crosstalk of mTOR/S6K1 and Hedgehog Pathways
Wang, Y., Ding, Q., Yen, C.-J., Xia, W., Izzo, J. G., Lang, J.-Y., Li, C.-W., Hsu, J. L., Miller, S. A., Wang, X., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2011.12.028 · Cited by 346
Kim, J., Aftab, B. T., Tang, J. Y., Kim, D., Lee, A. H., Rezaee, M., Kim, J., Chen, B., King, E. M., Borodovsky, A., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2012.11.017 · Cited by 346
Notch and Wnt signals cooperatively control cell proliferation and tumorigenesis in the intestine
Fre, S., Pallavi, S. K., Huyghe, M., Laé, M., Janssen, K.-P., Robine, S., Artavanis-Tsakonas, S., & Louvard, D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900427106 · Cited by 345
Dennler, S., André, J., Alexaki, I., Li, A., Magnaldo, T., ten Dijke, P., Wang, X.-J., Verrecchia, F., & Mauviel, A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0491 · Cited by 342
Rizzo, P., Miao, H., D'Souza, G., Osipo, C., Yun, J., Zhao, H., Mascarenhas, J., Wyatt, D., Antico, G., Hao, L., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5744 · Cited by 341
Self-citationEspinosa, L., Inglés-Esteve, J., Aguilera, C., & Bigas, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304001200 · Cited by 337
Adipsin, a Biomarker of Gastrointestinal Toxicity Mediated by a Functional γ-Secretase Inhibitor
Searfoss, G. H., Jordan, W. H., Calligaro, D. O., Galbreath, E. J., Schirtzinger, L. M., Berridge, B. R., Gao, H., Higgins, M. A., May, P. C., & Ryan, T. P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307757200 · Cited by 336
Waaler, J., Machon, O., Tumova, L., Dinh, H., Korinek, V., Wilson, S. R., Paulsen, J. E., Pedersen, N. M., Eide, T. J., Machonova, O., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3336 · Cited by 328
Wise, a context-dependent activator and inhibitor of Wnt signalling
Itasaki, N., Jones, C. M., Mercurio, S., Rowe, A., Domingos, P. M., Smith, J. C., & Krumlauf, R. (2003) · Development · doi:10.1242/dev.00674 · Cited by 321
Krop, I., Demuth, T., Guthrie, T., Wen, P. Y., Mason, W. P., Chinnaiyan, P., Butowski, N., Groves, M. D., Kesari, S., Freedman, S. J., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.1540 · Cited by 318
Ma, H., Nguyen, C., Lee, K.-S., & Kahn, M. (2005) · Oncogene · doi:10.1038/sj.onc.1208433 · Cited by 307
Self-citationKim, J., Lee, J. J., Kim, J., Gardner, D., & Beachy, P. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006822107 · Cited by 304
Oncogenic KRAS Activates Hedgehog Signaling Pathway in Pancreatic Cancer Cells
Ji, Z., Mei, F. C., Xie, J., & Cheng, X. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611089200 · Cited by 296
Kim, D. J., Kim, J., Spaunhurst, K., Montoya, J., Khodosh, R., Chandra, K., Fu, T., Gilliam, A., Molgo, M., Beachy, P. A., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.9525 · Cited by 289
Networking of WNT, FGF, Notch, BMP, and Hedgehog Signaling Pathways during Carcinogenesis
Katoh, M. (2007) · Stem Cell Reviews · doi:10.1007/s12015-007-0006-6 · Cited by 288
Notch post-translationally regulates β-catenin protein in stem and progenitor cells
Kwon, C., Cheng, P., King, I. N., Andersen, P., Shenje, L., Nigam, V., & Srivastava, D. (2011) · Nature Cell Biology · doi:10.1038/ncb2313 · Cited by 284
Dishevelled and Wnt signaling: is the nucleus the final frontier?
Habas, R., & Dawid, I. B. (2005) · Journal of Biology · doi:10.1186/jbiol22 · Cited by 279
Numb is a suppressor of Hedgehog signalling and targets Gli1 for Itch-dependent ubiquitination
Marcotullio, L. D., Ferretti, E., Greco, A., De Smaele, E., Po, A., Sico, M. A., Alimandi, M., Giannini, G., Maroder, M., Screpanti, I., et al. (2006) · Nature Cell Biology · doi:10.1038/ncb1510 · Cited by 275
Cilloni, D., & Saglio, G. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1613 · Cited by 274
Notch inhibitors for cancer treatment
Espinoza, I., & Miele, L. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.02.003 · Cited by 273
Self-citationGlycogen Synthase Kinase-3β Modulates Notch Signaling and Stability
Foltz, D. R., Santiago, M. C., Berechid, B. E., & Nye, J. S. (2002) · Current Biology · doi:10.1016/s0960-9822(02)00888-6 · Cited by 271
Tolcher, A. W., Messersmith, W. A., Mikulski, S. M., Papadopoulos, K. P., Kwak, E. L., Gibbon, D. G., Patnaik, A., Falchook, G. S., Dasari, A., Shapiro, G. I., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.8282 · Cited by 268
The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells
Smith, M.-L., Hawcroft, G., & Hull, M. A. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00333-0 · Cited by 252
NOTCH1-RBPJ complexes drive target gene expression through dynamic interactions with superenhancers
Wang, H., Zang, C., Taing, L., Arnett, K. L., Wong, Y. J., Pear, W. S., Blacklow, S. C., Liu, X. S., & Aster, J. C. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315023111 · Cited by 252
Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway
Jagani, Z., Mora-Blanco, E. L., Sansam, C. G., McKenna, E. S., Wilson, B., Chen, D., Klekota, J., Tamayo, P., Nguyen, P. T. L., Tolstorukov, M., et al. (2010) · Nature Medicine · doi:10.1038/nm.2251 · Cited by 251
Non-canonical Notch signaling: emerging role and mechanism
Andersen, P., Uosaki, H., Shenje, L. T., & Kwon, C. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2012.02.003 · Cited by 238
Escobar, C., Munker, R., Thomas, J. O., Li, B. D., & Burton, G. V. (2012) · Annals of Oncology · doi:10.1093/annonc/mdr386 · Cited by 235
The Anti-apoptotic Effect of Notch-1 Requires p56 -dependent, Akt/PKB-mediated Signaling in T Cells
Sade, H., Krishna, S., & Sarin, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309924200 · Cited by 233
Deadly crosstalk: Notch signaling at the intersection of EMT and cancer stem cells
Espinoza, I., & Miele, L. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.08.027 · Cited by 232
Self-citationFujii, N., You, L., Xu, Z., Uematsu, K., Shan, J., He, B., Mikami, I., Edmondson, L. R., Neale, G., Zheng, J., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2726 · Cited by 232
Control of β‐Catenin Signaling in Tumor Development
BEHRENS, J. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06698.x · Cited by 229
Deangelo, D. J., Stone, R. M., Silverman, L. B., Stock, W., Attar, E. C., Fearen, I., Dallob, A., Matthews, C., Stone, J., Freedman, S. J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.24.18_suppl.6585 · Cited by 229
Chau, W. K., Ip, C. K., Mak, A. S. C., Lai, H.-C., & Wong, A. S. T. (2013) · Oncogene · doi:10.1038/onc.2012.290 · Cited by 220
Messersmith, W. A., Shapiro, G. I., Cleary, J. M., Jimeno, A., Dasari, A., Huang, B., Shaik, M. N., Cesari, R., Zheng, X., Reynolds, J. M., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0607 · Cited by 218
Interactions between Hedgehog proteins and their binding partners come into view
Beachy, P. A., Hymowitz, S. G., Lazarus, R. A., Leahy, D. J., & Siebold, C. (2010) · Genes & Development · doi:10.1101/gad.1951710 · Cited by 212
Jimeno, A., Gordon, M., Chugh, R., Messersmith, W., Mendelson, D., Dupont, J., Stagg, R., Kapoun, A. M., Xu, L., Uttamsingh, S., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2157 · Cited by 209
ErbB-2 inhibition activates Notch-1 and sensitizes breast cancer cells to a γ-secretase inhibitor
Osipo, C., Patel, P., Rizzo, P., Clementz, A. G., Hao, L., Golde, T. E., & Miele, L. (2008) · Oncogene · doi:10.1038/onc.2008.149 · Cited by 206
Self-citationDiscovery and Characterization of a Small Molecule Inhibitor of the PDZ Domain of Dishevelled
Grandy, D., Shan, J., Zhang, X., Rao, S., Akunuru, S., Li, H., Zhang, Y., Alpatov, I., Zhang, X. A., Lang, R. A., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.009647 · Cited by 201
Hassan, K. A., Wang, L., Korkaya, H., Chen, G., Maillard, I., Beer, D. G., Kalemkerian, G. P., & Wicha, M. S. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0370 · Cited by 199
Vincan, E., & Barker, N. (2008) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9156-4 · Cited by 198
Takebe, N., Warren, R. Q., & Ivy, S. P. (2011) · Breast Cancer Research · doi:10.1186/bcr2876 · Cited by 195
Self-citationRamaswamy, B., Lu, Y., Teng, K.-Y., Nuovo, G., Li, X., Shapiro, C. L., & Majumder, S. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1248 · Cited by 191
Notch signaling: targeting cancer stem cells and epithelial-to-mesenchymal transition
Miele, L., Espinoza, I., Pochampally, Watabe, & Xing, F. (2013) · OncoTargets and Therapy · doi:10.2147/ott.s36162 · Cited by 183
Self-citationBerlin, J., Bendell, J. C., Hart, L. L., Firdaus, I., Gore, I., Hermann, R. C., Mulcahy, M. F., Zalupski, M. M., Mackey, H. M., Yauch, R. L., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1800 · Cited by 181
The sonic hedgehog factor GLI1 imparts drug resistance through inducible glucuronidation
Zahreddine, H. A., Culjkovic-Kraljacic, B., Assouline, S., Gendron, P., Romeo, A. A., Morris, S. J., Cormack, G., Jaquith, J. B., Cerchietti, L., Cocolakis, E., et al. (2014) · Nature · doi:10.1038/nature13283 · Cited by 179
Ingram, W. J., McCue, K. I., Tran, T. H., Hallahan, A. R., & Wainwright, B. J. (2008) · Oncogene · doi:10.1038/sj.onc.1210767 · Cited by 176
Noncanonical Hedgehog Signaling
Brennan, D., Chen, X., Cheng, L., Mahoney, M., & Riobo, N. A. (2012) · Vitamins & Hormones · doi:10.1016/b978-0-12-394622-5.00003-1 · Cited by 172
The Notch Pathway Is Important in Maintaining the Cancer Stem Cell Population in Pancreatic Cancer
Abel, E. V., Kim, E. J., Wu, J., Hynes, M., Bednar, F., Proctor, E., Wang, L., Dziubinski, M. L., & Simeone, D. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091983 · Cited by 169
A Stochastic Model for Cancer Stem Cell Origin in Metastatic Colon Cancer
Odoux, C., Fohrer, H., Hoppo, T., Guzik, L., Stolz, D. B., Lewis, D. W., Gollin, S. M., Gamblin, T. C., Geller, D. A., & Lagasse, E. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5779 · Cited by 165
Novel Synthetic Antagonists of Canonical Wnt Signaling Inhibit Colorectal Cancer Cell Growth
Waaler, J., Machon, O., von Kries, J. P., Wilson, S. R., Lundenes, E., Wedlich, D., Gradl, D., Paulsen, J. E., Machonova, O., Dembinski, J. L., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1282 · Cited by 165
Dumortier, A., Durham, A.-D., Di Piazza, M., Vauclair, S., Koch, U., Ferrand, G., Ferrero, I., Demehri, S., Song, L. L., Farr, A. G., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009258 · Cited by 164
Self-citationFilbin, M. G., Dabral, S. K., Pazyra‐Murphy, M. F., Ramkissoon, S. H., Kung, A. L., Pak, E., Chung, J. Y., Theisen, M., Sun, Y., Franchetti, Y., et al. (2013) · Nature Medicine · doi:10.1038/nm.3328 · Cited by 162
The Difficulty of Targeting Cancer Stem Cell Niches
LaBarge, M. A. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2933 · Cited by 162
Prostate tumor progression is mediated by a paracrine TGF-β/Wnt3a signaling axis
Li, X., Placencio, V. R., Iturregui, J. M., Uwamariya, C., Sharif‐Afshar, A., Koyama, T., Hayward, S. W., & Bhowmick, N. A. (2008) · Oncogene · doi:10.1038/onc.2008.293 · Cited by 159
Nuclear IKK activity leads to dysregulated Notch-dependent gene expression in colorectal cancer
Fernández‐Majada, V., Aguilera, C., Villanueva, A., Vilardell, F., Robert‐Moreno, A., Aytés, À., Real, F. X., Capellá, G., Mayo, M. W., Espinosa, L., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606476104 · Cited by 154
A phase II study of RO4929097 in metastatic colorectal cancer
Strosberg, J., Yeatman, T. J., Weber, J., Coppola, D., Schell, M. J., Han, G., Almhanna, K., Kim, R. D., Valone, T., Jump, H., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.02.056 · Cited by 152
Stoeck, A., Lejnine, S., Truong, A. S., Li, P., Wang, H., Zang, C., Yuan, J., Ware, C., Maclean, J. K. F., Garrett-Engele, P. W., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0830 · Cited by 151
Suppressing Wnt Signaling by the Hedgehog Pathway through sFRP-1
He, J., Sheng, T., Stelter, A. A., Li, C., Zhang, X., Sinha, M., Luxon, B. A., & Xie, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c600200200 · Cited by 149
Saito, N., Fu, J., Zheng, S., Yao, J., Wang, S., Liu, D. D., Yuan, Y., Sulman, E. P., Lang, F. F., Colman, H., et al. (2013) · Stem Cells · doi:10.1002/stem.1528 · Cited by 148
Izrailit, J., Berman, H. K., Datti, A., Wrana, J. L., & Reedijk, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1214014110 · Cited by 147
Grudzien, P., Lo, S. S., Albain, K. S., Robinson, P. A., Rajan, P. B., Strack, P. R., Golde, T. E., Miele, L., & Foreman, K. E. (2010) · PubMed · Cited by 143
Self-citationPandya, K., Meeke, K., Clementz, A. G., Rogowski, A., Roberts, J., Miele, L., Albain, K. S., & Osipo, C. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.321 · Cited by 140
Self-citationNotch-1 activates estrogen receptor-α-dependent transcription via IKKα in breast cancer cells
Hao, L., Rizzo, P., Osipo, C., Pannuti, A., Wyatt, D. L., Cheung, L. W.-K., Sonenshein, G. E., Osborne, B. A., & Miele, L. (2009) · Oncogene · doi:10.1038/onc.2009.323 · Cited by 139
Self-citationMurthy, A., Shao, Y. W., Narala, S., Molyneux, S. D., Zúñiga‐Pflücker, J. C., & Khokha, R. (2012) · Immunity · doi:10.1016/j.immuni.2012.01.005 · Cited by 138
Perumalsamy, L. R., Nagala, M., & Sarin, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910060107 · Cited by 133
Kaye, S. B., Fehrenbacher, L., Holloway, R. W., Amit, A., Karlan, B. Y., Slomovitz, B. M., Sabbatini, P. J., Fu, L., Yauch, R. L., Chang, I., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1796 · Cited by 131
What makes cancer stem cell markers different?
Karsten, U. R., & Goletz, S. (2013) · SpringerPlus · doi:10.1186/2193-1801-2-301 · Cited by 130
NOTCH inhibition and glucocorticoid therapy in T-cell acute lymphoblastic leukemia
Real, P. J., & Ferrando, A. A. (2009) · Leukemia · doi:10.1038/leu.2009.75 · Cited by 128
A phase I first-in-human study of PRI-724 in patients (pts) with advanced solid tumors.
El-Khoueiry, A. B., Ning, Y., Yang, D., Cole, S., Kahn, M. R., Zoghbi, M., Berg, J., Fujimori, M., Inada, T., Kouji, H., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.31.15_suppl.2501 · Cited by 125
Self-citationPerumalsamy, L. R., Nagala, M., Banerjee, P., & Sarin, A. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.20 · Cited by 121
Lee, K., Wu, Z., Song, Y., Mitra, S. S., Feroze, A. H., Cheshier, S. H., & Lu, B. (2013) · Genes & Development · doi:10.1101/gad.225169.113 · Cited by 115
Yoshizumi, T., Ohta, T., Ninomiya, I., Terada, I., Fushida, S., Fujimura, T., Nishimura, G., Shimizu, K., Yi, S., & Miwa, K. (2004) · International Journal of Oncology · doi:10.3892/ijo.25.3.631 · Cited by 107
Sulindac Inhibits Canonical Wnt Signaling by Blocking the PDZ Domain of the Protein Dishevelled
Lee, H., Wang, N. X., Shi, D., & Zheng, J. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200902981 · Cited by 103
Varnat, F., Siegl‐Cachedenier, I., Malerba, M., Gervaz, P., & Altaba, A. R. I. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000098 · Cited by 101
Arco, P. G., Kashiwagi, M., Jackson, A. F., Naito, T., Zhang, J., Liu, F., Kee, B. L., Vooijs, M., Radtke, F., Redondo, J. M., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.11.008 · Cited by 99
Synergistic Effect of the γ-Secretase Inhibitor PF-03084014 and Docetaxel in Breast Cancer Models
Zhang, C. C., Yan, Z., Zong, Q., et al. (2013) · Stem Cells Translational Medicine · doi:10.5966/sctm.2012-0096 · Cited by 94
A Pilot Phase II Study of Valproic Acid for Treatment of Low-Grade Neuroendocrine Carcinoma
Mohammed, T. A., Holen, K. D., Jaskula‐Sztul, R., Mulkerin, D. L., Lubner, S. J., Schelman, W. R., Eickhoff, J. C., Chen, H., & LoConte, N. K. (2011) · The Oncologist · doi:10.1634/theoncologist.2011-0031 · Cited by 92
Notch signals in the endothelium and cancer "stem-like" cells: opportunities for cancer therapy
Gu, J.-W., Rizzo, P., Pannuti, A., Golde, T. E., Osborne, B. A., & Miele, L. (2012) · Vascular Cell · doi:10.1186/2045-824x-4-7 · Cited by 87
Self-citationRoderick, J. E., González‐Pérez, G., Kuksin, C. A., Dongre, A., Roberts, E. R., Srinivasan, J., Andrzejewski, C., Fauq, A. H., Golde, T. E., Miele, L., et al. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20112615 · Cited by 86
Self-citationAntitumor Efficacy Testing in Rodents
Hollingshead, M. G. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn351 · Cited by 83
Smith, D. C., Rosen, L. S., Chugh, R. K., Goldman, J. W., Xu, L., Kapoun, A. M., Brachmann, R. K., Dupont, J., Stagg, R., Tolcher, A. W., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.31.15_suppl.2540 · Cited by 81
Dakubo, G. D., Mazerolle, C. J., & Wallace, V. A. (2006) · Journal of Neuro-Oncology · doi:10.1007/s11060-006-9132-2 · Cited by 78
Sahebjam, S., Bedard, P. L., Castonguay, V., Chen, Z., Reedijk, M., Liu, G., Cohen, B. L., Zhang, W.-J., Clarke, B. A., Zhang, T., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.380 · Cited by 75
Self-citationMesenchymal Stromal Cell Mutations and Wound Healing Contribute to the Etiology of Desmoid Tumors
Carothers, A. M., Rizvi, H. A., Hasson, R. M., Heit, Y. I., Davids, J. S., Bertagnolli, M. M., & Cho, N. L. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2819 · Cited by 71
Pietanza, M. C., Litvak, A. M., Varghese, A. M., Krug, L. M., Fleisher, M., Teitcher, J. B., Holodny, A. I., Sima, C. S., Woo, K. M., Ng, K., et al. (2016) · Lung Cancer · doi:10.1016/j.lungcan.2016.04.014 · Cited by 68
Determining Mammosphere-Forming Potential: Application of the Limiting Dilution Analysis
Rota, L. M., Lazzarino, D. A., Ziegler, A. N., LeRoith, D., & Wood, T. L. (2012) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-012-9258-0 · Cited by 66
Sjölund, J., Boström, A.-K., Lindgren, D., Manna, S., Moustakas, A., Ljungberg, B., Johansson, M., Fredlund, E., & Axelson, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023057 · Cited by 66
Eradication of pathogenic β-catenin by Skp1/Cullin/F box ubiquitination machinery
Su, Y., Ishikawa, S., Kojima, M., & Liu, B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2133261100 · Cited by 63
Crosstalk between PKCα and Notch-4 in endocrine-resistant breast cancer cells
Yun, J., Pannuti, A., Espinoza, I., Zhu, H., Hicks, C., Zhu, X., Caskey, M. W., Rizzo, P., D'Souza, G., Backus, K. V., et al. (2013) · Oncogenesis · doi:10.1038/oncsis.2013.26 · Cited by 62
Self-citationShou, Y., Robinson, D., Amakye, D. D., Rose, K. L., Cho, Y., Ligon, K. L., Sharp, T., Haider, A. S., Bandaru, R., Ando, Y., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1711 · Cited by 59
Rabadán, M. A., Cayuso, J., Dréau, G. L., Cruz, C., Barzi, M., Pons, S., Briscoe, J., & Martí, E. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.84 · Cited by 56
Noncanonical Regulation of the Hedgehog Mediator GLI1 by c-MYC in Burkitt Lymphoma
Yoon, J. W., Gallant, M. L., Lamm, M. L. G., Iannaccone, S., Vieux, K.-F., Proytcheva, M. A., Hyjek, E. M., Iannaccone, P. M., & Walterhouse, D. O. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0441 · Cited by 54
Jesus‐Acosta, A. D., O'Dwyer, P. J., Ramanathan, R. K., Hoff, D. D. V., Maitra, A., Rasheed, Z. A., Zheng, L., Rajeshkumar, N. V., Le, D. T., Hoering, A., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.32.3_suppl.257 · Cited by 53
Lehmann, C. H. K., JOBS, G., Thomas, M., BURTSCHER, H. J., & Kubbies, M. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1654 · Cited by 51
Yao, H., Ashihara, E., Strovel, J. W., Nakagawa, Y., Kuroda, J., Nagao, R., Tanaka, R., Yokota, A., Takeuchi, M., Hayashi, Y., et al. (2011) · Blood Cancer Journal · doi:10.1038/bcj.2011.41 · Cited by 48
Targeting Met and Notch in theLfng-deficient,Met-amplified triple-negative breast cancer
Zhang, S., Chung, W.-C., Miele, L., & Xu, K. (2014) · Cancer Biology & Therapy · doi:10.4161/cbt.28180 · Cited by 43
Self-citationArcaroli, J. J., Quackenbush, K. S., Purkey, A., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.361 · Cited by 41
Therapeutic promise and challenges of targeting DLL4/NOTCH1
Yan, M. (2011) · Vascular Cell · doi:10.1186/2045-824x-3-17 · Cited by 40
Distinct Spatial and Molecular Features of Notch Pathway Assembly in Regulatory T Cells
Perumalsamy, L. R., Marcel, N., Kulkarni, S., Radtke, F., & Sarin, A. (2012) · Science Signaling · doi:10.1126/scisignal.2002859 · Cited by 40
Catenacci, D. V. T., Bahary, N., Nattam, S. R., Marsh, R., Wallace, J. A., Rajdev, L. N., Cohen, D. J., Sleckman, B. G., Lenz, H., Stiff, P. J., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.31.15_suppl.4012 · Cited by 39
Sonic Hedgehog Acts as a Negative Regulator of β-Catenin Signaling in the Adult Tongue Epithelium
Schneider, F. T., Schänzer, A., Czupalla, C. J., Thom, S., Engels, K., Schmidt, M. H. H., Plate, K. H., & Liebner, S. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.091079 · Cited by 38
GSK3 is a negative regulator of the transcriptional coactivator MAML1
Ribeiro, M. S. J., Hansson, M. L., Lindberg, M. J., Popko-Ścibor, A. E., & Wallberg, A. E. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp724 · Cited by 36
Notch1 phenotype and clinical stage progression in non-small cell lung cancer
Nguyen, D., Rubinstein, L., Takebe, N., Miele, L., Tomaszewski, J. E., Ivy, P. S., Doroshow, J. H., & Yang, S. X. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-014-0104-2 · Cited by 29
Self-citationDiscovery and Exploitation of Novel Targets by Approved Drugs
Dirix, L. Y. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.7118 · Cited by 23
Albain, K. S., Czerlanis, C. M., Zlobin, A., Covington, K., Rajan, P., Godellas, C. V., Bova, D., Lo, S., Robinson, P., Sarker, S., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.sabcs11-s1-5 · Cited by 18
Self-citationSmith, D. C., Gordon, M. S., Messersmith, W. A., Chugh, R. K., Mendelson, D. S., Dupont, J., Stagg, R., Kapoun, A. M., Xu, L., Brachmann, R. K., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.targ-13-b79 · Cited by 17
Jimeno, A., LoRusso, P., Strother, R. M., Diamond, J. R., Plato, L., Younger, A., Messersmith, W. A., Kittaneh, M., Sawyer, D., Adriaens, L., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.31.15_suppl.2502 · Cited by 15
Sloan, A. E., Nock, C. J., Ye, X., Kerstetter, A. E., Supko, J., Lamborn, K. R., Rich, J. N., Miller, R. H., Takebe, N., Prados, M. D., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.32.15_suppl.2026 · Cited by 13
Self-citationMigden, M. R., Guminski, A. D., Gutzmer, R., Dirix, L. Y., Lewis, K. D., Combemale, P., Herd, R., Gogov, S., Yi, T., Mone, M. D., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.32.15_suppl.9009a · Cited by 12
Mortier, L., Saïag, P., Leccia, M. ‐., Mahmoudi, A., Mirakovska, L., Meddour, D., Duhamel, A., Mirabel, X., & Guerreschi, P. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.32.15_suppl.tps9104 · Cited by 8
Messersmith, W. A., LoRusso, P. M., Cleary, J. M., Dasari, A. N., Huang, B., Shaik, N. M., Cesari, R., McLachlan, K. R., Kern, K. A., & Shapiro, G. I. (2012) · European Journal of Cancer · doi:10.1016/s0959-8049(12)72385-7 · Cited by 7
Cited by
Batlle, E., & Clevers, H. (2017) · Nature Medicine · doi:10.1038/nm.4409 · Cited by 2,769
Combination therapy in combating cancer
Mokhtari, R. B., Homayouni, T. S., Baluch, N., Morgatskaya, E., Kumar, S., Das, B., & Yeger, H. (2017) · Oncotarget · doi:10.18632/oncotarget.16723 · Cited by 2,543
Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment
Phi, L. T. H., Sari, I. N., Yang, Y.-G., Lee, S.-H., Jun, N., Kim, K. S., Lee, Y. K., & Kwon, H. Y. (2018) · Stem Cells International · doi:10.1155/2018/5416923 · Cited by 994
Small-cell lung cancer: what we know, what we need to know and the path forward
Gazdar, A. F., Bunn, P. A., & Minna, J. D. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.87 · Cited by 904
Opportunities and challenges of radiotherapy for treating cancer
Schaue, D., & McBride, W. H. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.120 · Cited by 784
Metadata
- Authors
- Takebe, N., Miele, L., Harris, P. J., Jeong, W., Bando, H., Kahn, M., Yang, S. X., & Ivy, S. P.
- Venue
- Nature Reviews Clinical Oncology
- Published
- 2015-04-07
- Volume
- 12
- Issue
- 8
- Pages
- 445-464
- ISSN
- 1759-4774 (ISSN-L)
- 1759-4782
- OpenAlex
- W2039109621
- Cited by
- 1,298
- References
- 161
- FWCI
- 16.19
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.